Serological Test Segment is expected to grow with high CAGR during the forecast period GLOBAL LYME DISEASE DIAGNOSTICS MARKET SEGMENTATION: Rising enthusiasm of key players towards Research & Development of Lyme disease diagnosis is expected to drive the growth of the market. Increasing focus of governments towards well establishment of healthcare facilities, growing prevalence of Lyme disease and the emergence of new Lyme disease diagnostic tests are expected to drive the growth of the Global Lyme Disease Diagnostics market. Global Lyme Disease Diagnostics Market is expected to reach USD 3.7 billion, growing at a CAGR of 6.8% during forecast period. Global Lyme Disease Diagnostics Market is expected to project a CAGR of 6.8% during the forecast period, 2022-2032 The diagnostics intended to trat the lyme disease are called Lyme disease diagnostics. By prolonging the disease without treating it, results in heart, joint and CNS disorders and might become fatal. Early detection of the disease may be treated with antibiotics. The symptoms of Lyme disease in infected patients are fever, skin rashes, depression & fatigue. This is spread through the bite of infected ticks in humans. Lyme disease is occurred due to a bacterial infection by borrelia species. New York, J(GLOBE NEWSWIRE) - announces the release of the report "Lyme Disease Diagnostics Market Size, Share, and Analysis, By Diagnostic Technology, By Sample, By End User and Regional Forecasts, 2022-2032". Lyme Disease Diagnostics Market Size, Share, and Analysis, By Diagnostic Technology (Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and others), By Sample (Blood, Cerebrospinal Fluid, Joint Fluid, Urine), By End User (Hospitals, Public/Private Laboratories and Physicians Office) and Regional Forecasts, 2022-2032.
0 Comments
Leave a Reply. |